PetIQ - PETQ Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12 month target prices for PetIQ's shares. Their PETQ share price forecasts range from $21.00 to $30.00. On average, they predict the company's stock price to reach $25.50 in the next twelve months. This suggests a possible upside of 269.6% from the stock's current price.
View analysts price targets for PETQ or view top-rated stocks among Wall Street analysts.

PetIQ's stock was trading at $22.71 on January 1st, 2022. Since then, PETQ shares have decreased by 69.6% and is now trading at $6.90.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our PETQ earnings forecast.

PetIQ, Inc. (NASDAQ:PETQ) released its earnings results on Tuesday, August, 9th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.18. The company earned $252.01 million during the quarter, compared to analyst estimates of $259.28 million. PetIQ had a positive trailing twelve-month return on equity of 9.27% and a negative net margin of 1.53%.

PetIQ issued an update on its third quarter 2022 earnings guidance on Tuesday, September, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $200.00 million-$210.00 million, compared to the consensus revenue estimate of $237.33 million.

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

(PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETQ stock can currently be purchased for approximately $6.90.

PetIQ (NASDAQ:PETQ) has a market capitalization of $202.93 million and generates $932.53 million in revenue each year. The company earns $-15,970,000.00 in net income (profit) each year or ($0.49) on an earnings per share basis.

The company employs 1,929 workers across the globe.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The official website for the company is www.petiq.com. The company can be reached via phone at (208) 939-8900 or via email at jeff.sonnek@icrinc.com.